TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

JSPR DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Jasper Therapeutics, Inc. Investors to Secure Counsel Before Important November 18 Deadline in Securities Class Action – JSPR

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Rosen Law Firm
JSPR DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Jasper Therapeutics, Inc. Investors to Secure Counsel Before Important November 18 Deadline in Securities Class Action – JSPR

Rosen Law Firm is notifying investors of a securities class action lawsuit against Therapeutics for allegedly making false or misleading statements about manufacturing controls and product prospects during the period of November 30, 2023 to July 3, 2025.

Insights
JSPR   negative

The lawsuit alleges the company made false statements about manufacturing controls, potentially misrepresenting product prospects and increasing risks for clinical trials, which suggests significant corporate governance and transparency issues